A clinical trial shows that immunotherapy for patients with lung cancer who are "difficult to treat" increases long-term survival.

Published Date: 12 Jul 2023

The cancer immunotherapy atezolizumab significantly increased the overall survival of advanced stage non-small cell lung cancer patients who were unable to receive treatment, according to a global study conducted by UCL and UCLH.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Charles III, King of Kings, is Cancerous.

2.

Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.

3.

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

4.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

5.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot